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Abstract
Alveolar soft part sarcoma (ASPS) is a rare, malignant mesenchymal tumor of distinctive clinical, morphologic,
ultrastructural, and cytogenetical characteristics. It typically arises in the extremities of adolescents and young adults,
but has also been documented in a number of unusual sites, thus causing diagnostic confusions both clinically and
morphologically. The molecular signature of ASPS is a specific der(17)t(X;17)(p11.2;q25) translocation, which results
in the fusion of TFE3 transcription factor gene at Xp11.2 with ASPL at 17q25. Recent studies have shown that the
ASPL-TFE3 fusion transcript can be identified by reverse-transcriptase polymerase chain reaction analysis and TFE3
gene rearragement can be detected using a dual-color, break apart fluorescence in situ hybridization assay in
paraffin-embedded tissue, and the resultant fusion protein can be detected immunohistochemically with antibody
directed to the carboxy terminal portion of TFE3. Herein, we report a unique case of ASPS presenting as an
asymptomatic mass in the lung of a 48 year-old woman without evidence of a primary soft tissue tumor elsewhere
at the time of initial diagnosis. To the best of our knowledge, this is the third report of such cases appearing in the
English language literature to date. We emphasize the differential diagnoses engendered by ASPS including a series
of tumors involving the lung that have nested and alveolar growth patterns, and both clear and eosinophilic
cytoplasm, and demonstrate the utility of molecular genetic analysis for TFE3 rearrangement and
immunohistochemistry for TFE3 antigen expression for arriving at accurate diagnosis.
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Background
Alveolar soft part sarcoma (ASPS) is a rare mesenchymal
neoplasm with a highly distinctive histologic appearance,
ultrastructure, and cytogenetic profile involving a non-
reciprocal t(X;17)(p11.2;q25) [1, 2]. The translocation fuses
the TFE3 transcription factor gene at Xp11.2 to ASPL
(ASPSCR1), a novel gene on chromosome 17q25 and pre-
sents as type 1 and 2 variants involving the fusion of the
first seven exons of the ASPL gene to exon 6 (type 1) or 5
(type 2) of the TFE3 transcription factor gene [3]. ASPS
most commonly occurs in the deep soft tissue of lower ex-
tremities in adolescents and young adults, or the head and
neck region, especially the tongue and orbit in infants and
children [1, 2], but has also been occasionally reported in a
variety of unusual locations including the lung, stomach,
liver, breast, larynx, heart, urinary bladder, and female gen-
tial tract [4–10]. When presented at these unusual sites
ASPS may significantly causes diagnostic challenges due to
its histologic overlap with a number of primary or second-
ary neoplasms ocurring in those sites. Herein, we present a
case of ASPS occurring primarily in the lung in a 48 year-
old woman without evidence of a primary soft tissue tumor
elsewhere at the time of initial diagnosis.
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Case presentation
A previouly healthy 48 year-old female patient was inci-
dentally identified to have a left-lung mass on thoracic
radiology for routine medical examination. Subsequent
computed tomograph (CT) scan demonstrated a well-
demarcated, partly lobulated, heterogeneously enhanced
mass measuring of 3.8 × 3.7 cm, located at the hilum of
left lung (Fig. 1). A lung cancer was suggested. Precuta-
neous needle biopsy of the mass revealed no evidence of
maligangce was noted. Left pneumonectomy with hilar
and mediastinal lymphadenectomy was performed and
no additional therapy was administered. Neither a his-
tory of a remote tumor nor other soft tissue or visceral
lesions was discovered on the patient. A follow-up
12 months after the initial surgery found the patient to
be at a good status with no evidence of tumor recur-
rence or metastasis.
The resection specimen was fixed in 10 % buffered
formalin. Tissue sections were routinely processed and
stained with hematoxylin and eosin. IHC analysis was per-
formed using advidin-biotin-complex immunoperoxidase
technique with a panel of commercially available primary
antibodies to the following antigens: cytokeratin AE1/AE3
(AE1/3, Dako, Denmark), cytokeratin 7 (CK7) (OV-TL12/
30, Dako), cytokeratin 20 (CK20), high molecular weight
cytokeratin (34βE12, Dako), vimentin (V9, Dako), Thyroid
transcription factor 1 (TTF1) (8G7G3/1, Dako), NapsinA
(polyclonal, Dako), CD10 (56C6, Dako), PAX8 (polyclonal,
Proteintech, China), smooth muscle actin (SMA) (1A4,
Dako), desmin (D33, Dako), TFE3 (polyclonal, Abcam,
UK), melan-A (A103, Dako), HMB45 (HMB45, Dako),
S100 protein (polyclonal, Dako), chromogranin (polyclonal,
Dako), synaptophysin (polyclonal, Dako), Hepatocyte
paraffin-1 (HepPar-1) (OCH1E5, Dako), CD34 (QBEnd/
10, Dako), myogenin (MyF4, Dako) and Ki67 (MIB-1,
Dako). Appropriate positive and negative controls were
run concurrently for all the markers tested. FISH assay for
TFE3 gene rearrangement [11] and RT-PCR amplification
and DNA sequence analysis for ASPL-TFE3 fusion tran-
script [12] were performed according to previously had
been suggested. For ASPL-TFE3 fusion FISH assay, the
bacterial artificial chromosome (BAC) clones RP11-
765O14 (195 kb) and RP11-665 F9 (176 kb), located
centromeric to the ASPL gene locus, were labeled with 5-
fluorescein dUTP. The BAC clones RP11-416B14 (182 kb)
and RP11-344 N17 (202 kb), located telomeric to the
TFE3 gene locus, were labeled with 5-ROX-dUTP. RT-
PCR analysis for ASPL-TFE3 fusion transcript was
performed using Qiagen OneStep RT-PCR kit (Qiagen,
German). Primer sequences uesd as followings: ASPL-E7-
F3: TCCAAGCCAAAGAAGTCC; TFE3-E6-R1: TCAA
GCAGATTCCCTGACAC. DNA sequencing of PCR
Fig. 1 Radiology of ASPS of the lung. Computed tomograph (CT) scan demonstrated a well-demarcated, lobulated, heterogeneously enhanced
mass located at the level of hilum of left lung
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Fig. 2 Microscopical features of ASPS of the lung. a and b The tumor overall demonstrated an expansile growth pattern with focally infiltrating
into the alveolar spaces. c The tumor was composed of nests and alveolus and separated by thin-walled fibrous septa that contained abundant
vascular networks and lymhoplasmacytic infiltrations. d-f The tumor cells were large, polygonal to round, and discohesive with voluminous
eosinophilic, to pale, to clear cytoplasm. g Pleomorphic nuclei with prominent eosinophilic nucleoli. H: Multinucleation
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products was performed using a Qiagen 3000 BioRobot
(Qiagen, German). Written informed consent was ob-
tained from the patient.
Macroscopic examination of the resected specimen re-
vealed a circumscribed but noncapsulated, lobular, firm
tumor of white-to-gray color that measured 3.5 × 3.2 ×
3.0 cm, and arised from the bronchus with lateral exten-
sion towards subpleural areas without gross evidence of
pleural contracture. Microscopically, the tumor overall
demonstrated an expansile and vaguely lobular growth
pattern (Fig. 2a) with limited invasive fronts where
tumor cells infiltrated focally into the alveolar spaces
(Fig. 2b) and bronchic cartilage. The tumor was com-
posed of predominantly of variable-sized nests and al-
veolus, separated by thin-walled fibrous septa that
contained abundant vascular networks and prominent
lymhoplasmacytic infiltrations (Fig. 2c). In tiny areas, a
trabecular arrangement, reminiscent of hepatocellular
carcinoma (HCC), was also noted. Cytologically, the
tumor cells were large, polygonal to round, and often
discohesive with voluminous deeply eosinophilic, to pale,
finely granular eosinophilic, to clear cytoplasm and dis-
tinct borders (Fig. 2d-f ). Frequently, the eosinophilic
cytoplasm of the cells shrunk and condensed away from
the membrane to the nucelus, creating an appearance
resembling the so-called “spider cells” commonly seen in
epithelioid perivascular epithelioid cell tumor (PEComa),
or rhabdoid cells. The nuclei were eccentrically placed
and were small, round with inconspicuous nucleoli, to
markedly enlarged, pleomorphic with vesicular chroma-
tin and prominent eosinophilic nucleoli (Fig. 2g). Multi-
nucleation was occasionally obseverd (Fig. 2h), mitoses
were scarce. Foci of microscopic necrosis and vascular
tumor invasion were noted (Fig. 3a-b). Evidence of any
squamous or cylindrical cell abnormalities or epithelial
tumor was lacking. The hilar and mediastinal lymph
nodes were free of tumor.
By IHC, the tumor cells showed diffuse and strong
nucler positivity for TFE3 (Fig. 4) but negativity for all
the other markers detected except for Ki67, which la-
beled approximate 10 % tumor cells. FISH assay of the
tumor cells showed a single interphase nucleus with split
red and green signals observed in approximate 15 % tu-
morous nuclei, indicating the presence of a TFE3 gene
rearrangement involving X chromosome (Fig. 5). RT-
PCR amplification and DNA sequence analysis identified
a type 1 ASPL-TFE3 fusion transcript with fusion of the
first seven exons of the ASPL gene to exon 6 of the
TFE3 transcription factor gene (Fig. 6). A diagnosis of
primary ASPS of the lung was rendered on the basis of
exclusion of a secondary ASPS and common and not-so-
common differential diagnoses of tumors reported in
the lung, and on the basis of morphology, IHC
(TFE3 positivity), and molecular genetics (TFE3 gene
rearrangement) supportive of ASPS.
Discussion
ASPS is a rare malignant mesenchymal tumor accounting
for less than 1 % of all soft tissue tumors [2]. Clinically, it
typically presents as a soft, painless, slow-growing mass
and most classically occurs in the deep soft tissue of the
extremities in adolescents and young adults (15–35 y of
age), with a female predominance [1, 2]. The most com-
mon locations include buttocks/thighs, legs/popliteal
fossa, chest wall/trunk, and the upper extremities. In chil-
dren and infants, the head and neck region including the
tongue and orbit, is a common location. Unusual primary
soft tissue locations include the retroperitoneum, medias-
tinum, and bone [4, 5]. Visceral organ, such as lung, liver
and brain, involving by ASPS mostly represents a metasta-
sis from a primary soft tissue tumor elsewhere. Hovever,
sporadic reports have certainly documented primary ASPS
of visceral organs including the lung, stomach, liver,
breast, larynx, heart, urinary bladder, and female gential
tract [8, 7, 6, 10, 9, 13]. Primary ASPS of lung is extraor-
dinarily rare, to the best knowledge of us, our case repre-
sents only the third one of such cases that have been
reported in the English language literature since the mid
Fig. 3 Microscopical features of ASPS of the lung. a and b Foci of microscopic necrosis and vascular tumor invasion were noted
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1960’s [14, 8]. The two previously reported cases were from
Japan, and Korea, respectively. However, the Japanese case
[14], which was initially described as a tumor arising from
the pulmonary vein at the lung hilus, had been questioned
by other authors as a tumor origining in the mediastinum
rather than in the lung [8]. In contrast to metastatic ASPS
of the lung that often radiologically appeared as muti-
ple and bilateral nodules, both our and the Corean
case [8] presented as a solitary, asymptomatic mass in
the lung, similar to primary ASPS that had been re-
ported in other visceral organs.
Histologically, ASPS mostly presents stereotypical mor-
phologic features with round nests and alveoli composed
of dyscohesive uniform polygonal neoplastic cells having
round nuclei with vesicular chromatin, a prominent nucle-
olus, and abundant cytoplasm containing PAS positive,
distase resistant crystals [2, 1]. However, the organoid ap-
pearance may be lacking and the tumor may be composed
of sheets of neoplastic cells. Rarely, ASPS may shows light
microscopic features that depart from the conventional
morphology and cause differential diagnostic confusions.
Our case showed several unusual morphologic features of
ASPS that have only been occasionally mentioned in
the literature, including heavy lymphocytic infiltrate,
anaplasia, clear cells, rhabdoid-like cells, and multinu-
cleation [1, 13].
The cell of origin or, better, line of differentiation
taken by ASPS is elusive, and attempts to investigate it
by ultrastructural and immunohistochemical studies
have failed to elucidate the line of differentiation, with
controversial results [2, 1]. Recently, the molecular sig-
nature of ASPS has been described as a specific unbal-
anced translocation: der(17)t(X;17)(p11.2;q25) [15]. This
translocation results in the fusion of TFE3 transcription
factor gene at Xp11.2 with ASPL at 17q25 [3, 12]. Re-
cent studies has shown that the ASPL-TFE3 fusion tran-
script can be identified by RT-PCR analysis and TFE3
gene rearragement can be detected using a dual-color,
break apart FISH assay in paraffin-embedded tissue,
both can be uesd as powerful tools for diagnosis of ASPS
[12, 16, 17], in addition, the resultant fusion protein can
be detected by IHC with an antibody directed to the car-
boxy terminal portion of TFE3 with high sensitivity and
specificity [18]; all the three tools were used in the
current case to confirm the diagnosis of ASPS in the
lung. TFE3 gene rearrangment by FISH assay and mod-
erate to strong nuclear TFE3 positivity by IHC are virtu-
ally pathognomonic for ASPS, Xp11.2 translocation
associated RCC [19], and a subset of PEComa that har-
bors TFE3 gene fusion [20]. Xp11.2 translocation associ-
ated RCC is a recently described category of renal tumor
that is characterized by a papillary architecture com-
posed of cells with voluminous clear or eosinophilic
cytoplasm and psammoma bodies. Genetically, Xp11.2
translocation associated RCC harbors a balanced
t(X;17)(p11.2;q25) translocation in the majority cases,
which is in contrast to that of ASPS [19, 21]. TFE3
gene fusion associated PEComa, a most recently de-
scribed subtype of PEComa that occurs primarily in
young adults of both renal and extrarenal, and fea-
tures of prominent epithelioid cells with alveolar
architecture, as well as an aggressive clinical course
[20]. FISH assay and RT-PCR analysis in these tumors
have shown TFE3 gene rearrangement and amplification,
respectively. However, the partner fusion gene of TFE3 in
PEComa is largely unknown nowadays [22, 23]. Distin-
guishing these tumors may need IHC for additional
markers (as discussed below).
Fig. 4 Immunohistochemical features of ASPS of the lung. By
immunohistochemistry, the tumor cells showed diffuse and strong
nucler positivity for TFE3
Fig. 5 Molecular genetic features of ASPS of the lung. TFE3 fluorescence
in situ hybridization assay showed 1 set of fusion signal and 1 set
of green and red split signal, indicating evidence of a TFE3 gene
rearrangement
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Although its high sensitivity and specificity for identifi-
cation of neoplasms with associated gene fusion, detec-
tion of TFE3 reactivity by IHC has been shown to be
technically difficult, not inrequently accompanied with
strong background stain, or even with false positive and
negative results [18]. In addition, significant TFE3 ex-
pression can ocassionally be seen in tumors that not har-
bor an associated gene fusion, such as granular cell
tumor [24], paraganglioma [12], and adrenocortical car-
cinoma [12], these findings are of particular importance
since all these tumors may show overlapping morpho-
logical features with ASPS.
The differential diagnosis in the current case is relatively
broad that includes the rhabdoid or large cell undifferenti-
ated lung carcinoma [25], paraganglioma [26], epithelioid
PEComa (clear cell sugar tumor) [27], malignant granular
cell tumor [28], melanoma, and metastatic carcinoma
such as RCC, adrenocortical carcinoma, and HCC [29].
Although careful histomorphologic investigation obviously
plays a critical role in this differential diagnosis, IHC, and
occasionally molecular genetic analysis will prove decisive,
as evidenced by the current case. Briefly, carcinomas of
pulmonary origin would be expected to show considerable
CK expression in most cases, whereas ASPS does not ex-
press CK. Metastatic Xp11.2 translocation associated RCC
may show only weak CK expression, but generally show
strong PAX8 nuclear expression, a finding not seen in
ASPS. Metastatic adrenocortical carcinoma and HCC
would be expected to show MelanA and HepPar-1 expres-
sion in the majority of cases, respectively, whereas ASPS
expresses neither of the two markers. Paraganglioma, but
not ASPS, expresses neuroendocrine markers, such as
chromogranin A and synaptophysin. Granular cell tumor
and melanoma typically display strong, uniform S100
protein expression, which is absent in ASPS. Expres-
sion of melanocytic markers, such as HMB45 and
MelanA, would be seen in melanoma and epithelial
PEComa, but not in ASPS.
Conclusions
In summary, we report a unique case of primary ASPS of
the lung. Because of its unusual anatomic presentation,
problems in diagnosis may arise. A detailed clinical his-
tory, histomorphology, as well as immunohistochemical
and molecular genetic studies may help separate this
tumor from other more common primary pulmonary and
metastatic neoplasms. This case highlights the ubiquitous
distribution of this tumor and the need to consider this
neoplasm in the differential diagnosis of primary pulmon-
ary lesions.
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